Welcome to our dedicated page for NEOGEN SEC filings (Ticker: NEOG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Neogen Corporation SEC filings document material events for an operating company focused on food safety and animal safety products. Recent 8-K filings cover quarterly results and financial condition, Regulation FD disclosures related to Petrifilm manufacturing validation, and exhibits containing earnings releases and business updates.
The company’s filings also record governance and leadership matters, including executive appointments and departures, compensatory arrangements, board committee assignments, annual meeting voting results, executive compensation votes, and auditor ratification. These disclosures provide formal records of Neogen’s public-company reporting, operating updates, governance structure and shareholder matters.
Neogen Corporation (NEOG) is soliciting proxies for its 2026 virtual annual meeting on October 1, 2026. Shareholders will vote on electing three Class III directors, an advisory say‑on‑pay resolution, ratifying BDO USA P.C. as auditor, expanding the Omnibus Incentive Plan, and increasing shares under the Employee Stock Purchase Plan.
The company reports fiscal 2026 as a turning point, with GAAP revenue down 3% but core revenue up 2%, and Food Safety fourth‑quarter revenue up 3% with core growth of about 6%. Neogen reduced inventory by 24%, improved on‑time delivery by 40%, cut net debt by $100 million, and lowered net leverage to under 3.5x. It targets roughly 30% Adjusted EBITDA margins and plans a 50% increase in R&D spending in fiscal 2027.
The amended Omnibus Incentive Plan would raise the share reserve by 11,350,000 to a total of 31,350,000 shares, while the ESPP amendment would add 5,000,000 shares for employee purchases, bringing that plan’s capacity to 6,000,000 shares.
NEOGEN CORP (NEOG) reported an insider equity event involving Chief Accounting Officer John Patrick Moylan. On August 19, 2026, restricted stock units vested, and 2,365 shares of common stock underlying those RSUs were disposed of through share withholding to cover tax liabilities. Following this tax-withholding disposition, Moylan directly held 29,331 shares of NEOG common stock.
NEOGEN CORP (NEOG) reported an insider equity transaction by CEO and director Mikheal Nassif. On August 19, 2026, restricted stock units vested on the anniversary of the grant date, and 20,397 shares of common stock were disposed of through share withholding to cover tax liabilities on the vested RSUs. Following this tax-withholding disposition, Nassif’s directly held common stock position is reported as 25,655 shares.
NEOGEN CORP’s Chief Accounting Officer, John Patrick Moylan, received new equity awards on August 14, 2026. He was granted options to buy 18,693 shares of common stock at an exercise price of $11.65 per share, expiring August 14, 2036, and 8,584 restricted stock units. Both the options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants. Following these awards, he directly holds 18,693 derivative option shares and 32,155 non-derivative shares/RSUs. The filing indicates these awards were not made under a Rule 10b5-1 trading plan.
Neogen Corp reported equity compensation awards to Senior Vice President Tamara A. Ranalli. She received options to acquire 130,851 shares of common stock at an exercise price of $11.65 per share, expiring on August 14, 2036. According to the footnote, these options vest in equal annual installments on each of the first three anniversaries of the grant date.
Ranalli also received a grant of 25,751 shares of common stock, described as PSUs, at a reference price of $11.65 per share. The PSUs vest in total at the end of the three-year anniversary date of the grant. All reported holdings following these awards are shown as directly owned.
NEOGEN CORP reported equity compensation awards to Chief Legal Officer Stacey Jennifer Evans on August 14, 2026. She received options to acquire 196,276 shares of common stock at an exercise price of $11.65 per share, expiring August 14, 2036, vesting in equal installments over three years. She also received 38,627 performance stock units, which vest in total at the end of a three-year period, with both positions reported as directly owned after the grants.
NEOGEN CORP reported equity awards to its CFO, Richard Bryan Riggsbee, on 2026-08-14. He received an option grant covering 261,702 shares of Common Stock at an exercise price of $11.65 per share, expiring on 2036-08-14. According to the disclosure, these options vest in equal annual installments over the first three anniversaries of the grant date.
On the same date, he also received a grant of 51,502 shares of Common Stock, referenced as PSUs, at a stated value of $11.65 per share. The PSUs vest in total at the end of the three-year anniversary of the grant date. Both positions are reported as directly owned following the transactions.
NEOGEN CORP CEO Mikheal Nassif reported two equity awards on August 14, 2026. He received options for 719,679 shares of common stock at an exercise price of $11.65 per share, expiring on August 14, 2036; these options vest in equal annual installments over three years. He also received 141,631 performance stock units (PSUs), which vest in total on the three-year anniversary of the grant. Following these awards, reported direct holdings are 141,631 common shares and 719,679 option-based rights.
Neogen Corporation reported that board member Thierry Bernard resigned from its Board of Directors, effective August 3, 2026. The change directly affects the company’s governance structure and the composition of its board.
The report is executed on behalf of Neogen Corporation by Chief Financial Officer R. Bryan Riggsbee.